OMRIVY
Live / Applied — Third extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 22 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98328201
- Mark type
- Stylized text
- Filed
- 22 Dec 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Sonali S. Srivastava
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience
Owner
- Cerevel Therapeutics, LLC, North Chicago, IL, US
- Cerevel Therapeutics, LLC, Cambridge, MA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 3 GRANTED
- 09 Mar 2026 — SOU EXTENSION 3 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2025 — SOU EXTENSION 2 GRANTED
- 10 Oct 2025 — SOU EXTENSION 2 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 1 GRANTED
- 28 Apr 2025 — SOU EXTENSION 1 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED